Virtu Financial LLC Biond Vax Pharmaceuticals Ltd. Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 17, 2022	SELL	$1.48 - $2.92 $32,935 - $64,981	-22,254 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.15 - $3.44 $47,846 - $76,553	22,254 New	22,254 $49,000
Q2 2021 Sep 17, 2021	SELL	$2.6 - $3.91 $47,652 - $71,662	-18,328 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$3.1 - $5.95 $56,816 - $109,051	18,328 New	18,328 $70,000
Q3 2020 Dec 11, 2020	SELL	$23.7 - $51.1 $270,796 - $583,868	-11,426 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$7.2 - $24.87 $82,267 - $284,164	11,426 New	11,426 $260,000

Ticker BVXV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,678,800
Market Cap $12M
Description
BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Götting...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.